| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 824.62M | 1.04B | 1.03B | 546.25M | 184.07M |
| Gross Profit | 123.45M | 411.68M | 441.64M | 95.12M | 22.58M |
| EBITDA | 197.36M | 460.05M | 465.04M | 163.44M | 35.92M |
| Net Income | 6.11M | 242.01M | 239.69M | 59.18M | -55.44M |
Balance Sheet | |||||
| Total Assets | 2.35B | 2.14B | 2.01B | 1.82B | 1.88B |
| Cash, Cash Equivalents and Short-Term Investments | 223.92M | 140.52M | 175.80M | 64.69M | 25.94M |
| Total Debt | 394.03M | 236.69M | 213.99M | 373.81M | 452.67M |
| Total Liabilities | 950.08M | 754.29M | 838.58M | 893.43M | 982.56M |
| Stockholders Equity | 1.23B | 1.25B | 1.17B | 928.03M | 896.39M |
Cash Flow | |||||
| Free Cash Flow | -25.74M | 34.54M | 348.07M | 152.69M | 34.45M |
| Operating Cash Flow | 202.74M | 223.49M | 481.88M | 233.78M | 84.91M |
| Investing Cash Flow | -241.86M | -177.91M | -172.30M | -87.92M | -56.76M |
| Financing Cash Flow | 118.06M | -80.43M | -197.58M | -103.87M | -41.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.10T | 17.31 | 12.12% | 8.97% | -6.04% | -7.87% | |
67 Neutral | HK$236.89B | 4.20 | 11.15% | 4.59% | -21.82% | -20.14% | |
65 Neutral | HK$13.24B | 16.31 | 3.92% | 9.28% | -0.02% | -59.00% | |
65 Neutral | HK$212.22B | 7.79 | 13.96% | 8.02% | 7.29% | -48.69% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
48 Neutral | HK$8.20B | 11.91 | 0.50% | ― | -20.89% | -97.28% | |
45 Neutral | HK$276.32M | -0.18 | -48.57% | ― | -10.83% | 1.54% |